Clinical trial
Comparison of CNI-based Regimen Versus CNI-free Regimen in Kidney Transplant…
NCT00332839 · Novartis Pharmaceuticals, Industry · Terminated
Key facts
| NCT number | NCT00332839 |
|---|---|
| Title | Comparison of CNI-based Regimen Versus CNI-free Regimen in Kidney Transplant Recipients. |
| Official title | Multi-center, Open-label, Prospective, Randomized, Parallel Group Study Investigating a CNI-free Regimen With Enteric-coated Mycophenolate Sodium and Everolimus in Comparison to Standard Therapy With Enteric-coated Mycophenolate Sodium and Ciclosporin Microemulsion in Stable Renal Transplant… |
| Lead sponsor | Novartis Pharmaceuticals, Industry |
| Status | Terminated |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Renal Transplantation |
| Intervention type | Drug |
| Interventions | Everolimus, Cyclosporin A (CsA), Tacrolimus, Enteric Coated - Mycophenolate Sodium (EC-MPS), Corticosteroids |
| Enrollment | 93 |
| Start date | Nov 1, 2005 |
| Primary completion | Mar 1, 2013 |
| Completion | Mar 1, 2013 |
| First posted | Jun 2, 2006 |
| Last update posted | Aug 28, 2014 |
| Countries | Germany |
At a glance
- 10–99 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: